SCHEMBL6676255

SCHEMBL6676255

O=C(O)C1(c2cccc([N+](=O)[O-])c2)CCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.53
KDM1A O60341 1/20 0.49
TP53 P04637 1/20 0.49
ALDH1A1 P00352 3/20 0.47
TSHR P16473 4/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 2/20 0.46
DDX3X O00571 1/20 0.46
HTT P42858 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676866 0.97 AKR1C1 (0.57) AKR1C1KDM1ATP53ALDH1A1TSHR
SCHEMBL6674979 0.95 AKR1C1 (0.56) AKR1C1KDM1ATP53ALDH1A1TSHR
SCHEMBL6679093 0.94 TP53 (0.51) AKR1C1KDM1ATP53ALDH1A1TSHR
SCHEMBL27256555 0.89 NPSR1 (0.46) AKR1C1KDM1ATP53ALDH1A1TSHR
SCHEMBL8097387 0.87 ALDH1A1 (0.50) KDM1ATP53ALDH1A1TSHRLMNA
SCHEMBL15054545 0.83 SLC6A4 (0.46) KDM1AALDH1A1TSHRLMNAMEN1
SCHEMBL30492221 0.82 KDM1A (0.50) KDM1ATP53ALDH1A1TSHRLMNA
SCHEMBL22832642 0.82 SMN1; SMN2 (0.50) KDM1ATP53ALDH1A1TSHRLMNA
SCHEMBL3224174 0.81 NPSR1 (0.55) AKR1C1ALDH1A1TSHRLMNAMEN1
SCHEMBL15054977 0.80 MEN1 (0.48) KDM1AALDH1A1TSHRLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
CN-1310169-A Anils with nitric oxide synzyme inhibiting function SHUGAI SEIYAKU K K (JP) 2001-08-29 CN disclosed
US-6124354-A TREATMENT OF URINARY INCONTINENCE OR IRRITABLE BOWEL SYNDROME PHARMACIA & UPJOHN AB (SE) 2000-09-26 US disclosed
EP-0923536-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1999-06-23 EP disclosed
WO-1998004517-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-02-05 WO disclosed
CN-1172473-A Aniline derivatives having nitric oxide synthase inhibitory activity CHUGAI PHARMACEUTICAL CO LTD (JP) 1998-02-04 CN disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed